Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 17/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.47 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.47 |
| ▸ | CCKBR | P32239 | 7/20 | 0.44 |
| ▸ | CCKAR | P32238 | 6/20 | 0.44 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | CTSS | P25774 | 1/20 | 0.42 |
| ▸ | CTSK | P43235 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22434527 | 1.00 | OPRD1 (0.47) | OPRD1OPRM1OPRK1CCKBRCCKAR | |
| SCHEMBL20763011 | 0.93 | OPRD1 (0.48) | OPRD1OPRM1OPRK1CCKBRCCKAR | |
| SCHEMBL20756477 | 0.93 | OPRD1 (0.48) | OPRD1OPRM1OPRK1CCKBRCCKAR | |
| SCHEMBL20614626 | 0.93 | OPRD1 (0.48) | OPRD1OPRM1OPRK1CCKBRCCKAR | |
| SCHEMBL22352135 | 0.93 | OPRD1 (0.48) | OPRD1OPRM1OPRK1CCKBRCCKAR | |
| SCHEMBL22352358 | 0.93 | OPRD1 (0.48) | OPRD1OPRM1OPRK1CCKBRCCKAR | |
| SCHEMBL20763448 | 0.93 | OPRD1 (0.48) | OPRD1OPRM1OPRK1CCKBRCCKAR | |
| SCHEMBL22753409 | 0.89 | OPRD1 (0.42) | OPRD1OPRM1OPRK1CCKBRCCKAR | |
| SCHEMBL20614625 | 0.80 | MMP1 (0.49) | ACE | |
| SCHEMBL20614509 | 0.80 | MMP1 (0.49) | ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11746126-B2 | Bicyclic peptide ligands with detectable moieties and uses thereof | Bicyclerd Limited (GB) | 2023-09-05 | — | — | US | disclosed |
| US-20210079045-A1 | BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE MOIETIES AND USES THEREOF | Bicyclerd Limited (GB) | 2021-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11746126-B2 | Bicyclic peptide ligands with detectable moieties and uses thereof | VIP, NGLY1, GRPR | OPRD1 3256/4885OPRM1 1992/4885OPRK1 2640/4885 |
| US-20210079045-A1 | BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE MOIETIES AND USES THEREOF | VIP, NGLY1, GRPR | OPRD1 3256/4885OPRM1 1992/4885OPRK1 2640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.